Geron Corporation - Common Stock (NQ:GERN)

1.160 +0.040 (+3.57%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 24, 2025 Add to My Watchlist

Price and Volume

Volume	7,017,769
Open	1.120
Bid (Size)	1.140 (5,500)
Ask (Size)	1.160 (600)
Prev. Close	1.120
Today's Range	1.110 - 1.160
52wk Range	1.040 - 4.205
Shares Outstanding	508,766,846
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Geron Corp (NASDAQ:GERN) Reports Mixed Q3 2025 Results, Misses Revenue Estimates ↗

November 05, 2025

Geron's Q3 2025 results show mixed performance, with RYTELO revenue up 67% year-over-year but missing analyst sales estimates, causing a negative market reaction.

Via Chartmill

Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights

November 05, 2025

From Geron Corporation

Via Business Wire

Performance

YTD	-67.8%	-67.8%
1 Month	-9.4%	-9.4%
3 Month	-18.3%	-18.3%
6 Month	-22.1%	-22.1%
1 Year	-71.7%	-71.7%

More News

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Geron Earnings Preview ↗

November 04, 2025

Via Benzinga

Geron Corporation to Present at Upcoming Investor Conferences

November 04, 2025

From Geron Corporation

Via Business Wire

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies

November 03, 2025

From Geron Corporation

Via Business Wire

Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025

October 27, 2025

From Geron Corporation

Via Business Wire

GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 23, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 20, 2025

From Geron Corporation

Via Business Wire

Geron to Participate in the 2025 Wells Fargo Healthcare Conference

August 27, 2025

From Geron Corporation

Via Business Wire

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 18, 2025

From Geron Corporation

Via Business Wire

GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

August 13, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 08, 2025

From Geron Corporation

Via Business Wire

Geron (GERN) Q2 Revenue Jumps 5,477% ↗

August 06, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 06, 2025

Via Benzinga

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

August 06, 2025

From Geron Corporation

Via Business Wire

Geron Appoints Harout Semerjian as President and Chief Executive Officer

August 06, 2025

From Geron Corporation

Via Business Wire

Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025

July 28, 2025

From Geron Corporation

Via Business Wire

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 18, 2025

From Geron Corporation

Via Business Wire

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 18, 2025

From Geron Corporation

Via Business Wire

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program

May 28, 2025

From Geron Corporation

Via Business Wire

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 19, 2025

From Geron Corporation

Via Business Wire

GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

May 15, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

May 12, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

Frequently Asked Questions

Is Geron Corporation - Common Stock publicly traded?

Yes, Geron Corporation - Common Stock is publicly traded.

What exchange does Geron Corporation - Common Stock trade on?

Geron Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Geron Corporation - Common Stock?

The ticker symbol for Geron Corporation - Common Stock is GERN on the Nasdaq Stock Market

What is the current price of Geron Corporation - Common Stock?

The current price of Geron Corporation - Common Stock is 1.160

When was Geron Corporation - Common Stock last traded?

The last trade of Geron Corporation - Common Stock was at 11/24/25 04:00 PM ET

What is the market capitalization of Geron Corporation - Common Stock?

The market capitalization of Geron Corporation - Common Stock is 590.17M

How many shares of Geron Corporation - Common Stock are outstanding?

Geron Corporation - Common Stock has 590M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.